Latest Insider Transactions at Intuitive Surgical Inc (ISRG)
This section provides a real-time view of insider transactions for Intuitive Surgical Inc (ISRG). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of INTUITIVE SURGICAL INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of INTUITIVE SURGICAL INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 15
2022
|
Fredrik Widman VP Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
328
-9.4%
|
$94,792
$289.31 P/Share
|
|
Feb 15
2022
|
Fredrik Widman VP Corporate Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
879
+19.99%
|
-
|
|
Feb 15
2022
|
Gary S Guthart CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,455
-33.3%
|
$998,495
$289.31 P/Share
|
|
Feb 15
2022
|
Gary S Guthart CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,998
+43.47%
|
-
|
|
Feb 15
2022
|
Marshall Mohr Executive VP Global Business S |
SELL
Payment of exercise price or tax liability
|
Direct |
1,417
-27.46%
|
$409,513
$289.31 P/Share
|
|
Feb 15
2022
|
Marshall Mohr Executive VP Global Business S |
BUY
Exercise of conversion of derivative security
|
Direct |
3,873
+42.23%
|
-
|
|
Feb 15
2022
|
Henry L Charlton SVP & Chief Commercial and Mkt |
SELL
Payment of exercise price or tax liability
|
Direct |
972
-3.11%
|
$280,908
$289.31 P/Share
|
|
Feb 15
2022
|
Henry L Charlton SVP & Chief Commercial and Mkt |
BUY
Exercise of conversion of derivative security
|
Direct |
3,186
+9.23%
|
-
|
|
Feb 15
2022
|
David J. Rosa President |
SELL
Payment of exercise price or tax liability
|
Direct |
2,160
-0.94%
|
$624,240
$289.31 P/Share
|
|
Feb 15
2022
|
David J. Rosa President |
BUY
Exercise of conversion of derivative security
|
Direct |
5,373
+2.27%
|
-
|
|
Feb 15
2022
|
Reiter Kara Andersen Sr VP General Counsel & CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,153
-3.44%
|
$333,217
$289.31 P/Share
|
|
Feb 15
2022
|
Reiter Kara Andersen Sr VP General Counsel & CCO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,279
+8.88%
|
-
|
|
Feb 15
2022
|
Jamie Samath |
SELL
Payment of exercise price or tax liability
|
Direct |
567
-15.24%
|
$163,863
$289.31 P/Share
|
|
Feb 15
2022
|
Jamie Samath |
BUY
Exercise of conversion of derivative security
|
Direct |
1,587
+29.62%
|
-
|
|
Feb 15
2022
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Payment of exercise price or tax liability
|
Direct |
1,831
-19.99%
|
$529,159
$289.31 P/Share
|
|
Feb 15
2022
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
4,998
+35.15%
|
-
|
|
Jan 25
2022
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Open market or private sale
|
Direct |
1,410
-23.75%
|
$368,010
$261.64 P/Share
|
|
Jan 25
2022
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
1,410
+18.97%
|
$297,510
$211.41 P/Share
|
|
Jan 25
2022
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,000
-91.32%
|
$1,578,000
$263.94 P/Share
|
|
Jan 25
2022
|
Myriam Curet EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+47.73%
|
$744,000
$124.51 P/Share
|
|
Dec 14
2021
|
David J. Rosa President |
SELL
Bona fide gift
|
Direct |
850
-0.25%
|
-
|
|
Nov 24
2021
|
Amal M Johnson |
SELL
Open market or private sale
|
Direct |
7,500
-41.28%
|
$2,497,500
$333.73 P/Share
|
|
Nov 24
2021
|
Amal M Johnson |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+29.22%
|
$480,000
$64.36 P/Share
|
|
Nov 10
2021
|
Amal M Johnson |
SELL
Bona fide gift
|
Direct |
500
-4.48%
|
-
|
|
Oct 25
2021
|
Marshall Mohr Executive VP Global Business S |
SELL
Open market or private sale
|
Direct |
20,475
-100.0%
|
$6,941,025
$339.2 P/Share
|
|
Oct 25
2021
|
Marshall Mohr Executive VP Global Business S |
BUY
Exercise of conversion of derivative security
|
Direct |
20,475
+50.0%
|
$1,208,025
$59.23 P/Share
|
|
Oct 22
2021
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Open market or private sale
|
Direct |
1,014
-18.79%
|
$343,746
$339.75 P/Share
|
|
Oct 22
2021
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
1,014
+15.8%
|
$213,954
$211.41 P/Share
|
|
Oct 22
2021
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,000
-95.47%
|
$2,034,000
$339.64 P/Share
|
|
Oct 22
2021
|
Myriam Curet EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+48.84%
|
$654,000
$109.49 P/Share
|
|
Oct 22
2021
|
Alan J Levy Director |
SELL
Open market or private sale
|
Direct |
7,500
-13.32%
|
$2,542,500
$339.64 P/Share
|
|
Oct 22
2021
|
Alan J Levy Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+11.71%
|
$480,000
$64.15 P/Share
|
|
Oct 22
2021
|
Jamie Samath |
SELL
Open market or private sale
|
Direct |
1,503
-24.37%
|
$509,517
$339.67 P/Share
|
|
Oct 22
2021
|
Jamie Samath |
BUY
Exercise of conversion of derivative security
|
Direct |
1,503
+19.44%
|
$270,540
$180.59 P/Share
|
|
Sep 09
2021
|
Mark J Rubash Director |
SELL
Open market or private sale
|
Direct |
1,196
-4.6%
|
$1,295,268
$1083.16 P/Share
|
|
Sep 09
2021
|
Mark J Rubash Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,196
+4.29%
|
$205,712
$172.6 P/Share
|
|
Sep 09
2021
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,250
-94.93%
|
$4,598,500
$1082.54 P/Share
|
|
Sep 09
2021
|
Myriam Curet EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,250
+48.7%
|
$1,202,750
$283.68 P/Share
|
|
Aug 26
2021
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Open market or private sale
|
Direct |
397
-52.17%
|
$416,056
$1048.12 P/Share
|
|
Aug 26
2021
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
397
+34.28%
|
$292,192
$736.8 P/Share
|
|
Aug 11
2021
|
Amal M Johnson |
SELL
Open market or private sale
|
Direct |
2,500
-40.17%
|
$2,502,500
$1001.63 P/Share
|
|
Aug 11
2021
|
Amal M Johnson |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+28.66%
|
$482,500
$193.08 P/Share
|
|
Aug 06
2021
|
David J. Rosa President |
SELL
Open market or private sale
|
Direct |
8,065
-17.7%
|
$8,153,715
$1011.9 P/Share
|
|
Aug 06
2021
|
David J. Rosa President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,500
+18.73%
|
$1,806,000
$172.44 P/Share
|
|
Aug 05
2021
|
David J. Rosa President |
SELL
Open market or private sale
|
Direct |
8,146
-18.85%
|
$8,203,022
$1007.23 P/Share
|
|
Aug 05
2021
|
David J. Rosa President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,500
+19.55%
|
$1,806,000
$172.44 P/Share
|
|
Aug 03
2021
|
Keith R Leonard Director |
SELL
Open market or private sale
|
Direct |
996
-53.98%
|
$996,000
$1000.0 P/Share
|
|
Aug 03
2021
|
Keith R Leonard Director |
BUY
Exercise of conversion of derivative security
|
Direct |
996
+35.06%
|
$460,152
$462.71 P/Share
|
|
Jul 26
2021
|
Marshall Mohr Executive VP Global Business S |
SELL
Open market or private sale
|
Direct |
6,825
-100.0%
|
$6,572,475
$963.38 P/Share
|
|
Jul 26
2021
|
Marshall Mohr Executive VP Global Business S |
BUY
Exercise of conversion of derivative security
|
Direct |
6,825
+50.0%
|
$1,167,075
$171.33 P/Share
|